Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
The article shows how different indices measure market breadth and why breadth trends matter for identifying trend strength and potential reversals.
27,800 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
July brings new questions about Nvidia's upside. Here are three strong reasons nvidia stock july could be a prudent m...
Meta just delivered a major update, but the stock still slid. This article explains what happened, why the move may b...
A Paychex insider recently moved tens of thousands of shares, prompting questions about the stock’s trajectory. This ...
As investors hunt for catalysts in 2026, the idea of a blockbuster stock split from Booking Holdings stands out. This...
Zscaler is steering its platform toward AI-driven security, aiming to reshape enterprise defense and investor returns...
Oil shipments face new risk as Iran signals deployment of sea mines in key chokepoints. Here’s how that could affect ...
When a company CEO sells thousands of shares, investors take notice. This guide breaks down what National Vision's so...
Keystone reveals a sizable new stake in the IDEF defense ETF, signaling growing investor interest in defense and indu...
Target delivered a solid beat-and-raise quarter, yet shares slid, illustrating a sell-the-news dynamic. With Walmart ...
A news-driven swing in Ondas stock sparked investor curiosity. This guide breaks down the catalysts, what it means fo...
Quanex (NX) is navigating a housing cycle and raw material costs as it shapes its 2026 earnings. This guide breaks do...